Short answer

BIOLIFE SOLUTIONS INC (BLFS) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $28M (up 14.9% year over year) with net income of $1M.

Q1 2026 key financials · XBRL

Revenue: $28M; +14.9% YoY
Net income: $1M; +364.7% YoY
Operating margin: 0.1%
Gross margin: 63.6%
EPS (diluted): $0.02; +300.0% YoY

Source: XBRL data from the BIOLIFE SOLUTIONS INC (BLFS) Q1 2026 10-Q on SEC EDGAR. USD.

BIOLIFE SOLUTIONS INC Q1 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

Revenue $27.5M, up 25% from $22.1M YoY, driven by biopreservation media demand
Gross margin 64% vs 67% YoY, pressured by less favorable product mix
Biopreservation media best-performing offering; lower-margin products weakened mix
Cash, equivalents, and securities $111.5M vs $120.2M; operating cash flow $(0.5)M vs $1.7M
Liquidity sufficient for at least twelve months; potential debt or equity financing, with capital availability risk

Risk Factors

No risk-factors section provided; excerpt contains Items 2–6 and signatures only
No newly added risk or material update identifiable from the supplied text
No regulatory, legal, compliance, operational, competitive, market, or financial risk disclosed in the excerpt

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.

Start free

BIOLIFE SOLUTIONS INC (BLFS) Q1 2026 10-Q Quarterly Report